PT Medikaloka Hermina Tbk (HEAL.JK)

IDR 1420.0

(-1.73%)

Net Income Summary of PT Medikaloka Hermina Tbk

PT Medikaloka Hermina Tbk's latest annual net income in 2023 was 437.34 Billion IDR , up 46.47% from previous year.
PT Medikaloka Hermina Tbk's latest quarterly net income in 2024 Q3 was 125 Billion IDR , down -17.88% from previous quarter.
PT Medikaloka Hermina Tbk reported an annual net income of 298.59 Billion IDR in 2022, down -70.02% from previous year.
PT Medikaloka Hermina Tbk reported an annual net income of 995.97 Billion IDR in 2021, up 54.26% from previous year.
PT Medikaloka Hermina Tbk reported a quarterly net income of 152.21 Billion IDR for 2024 Q2, down -20.29% from previous quarter.
PT Medikaloka Hermina Tbk reported a quarterly net income of 190.94 Billion IDR for 2024 Q1, up 115.74% from previous quarter.

Annual Net Income Chart of PT Medikaloka Hermina Tbk (2023 - 2015)

Historical Annual Net Income of PT Medikaloka Hermina Tbk (2023 - 2015)

Year	Net Income	Net Income Growth
2023	437.34 Billion IDR	46.47%
2022	298.59 Billion IDR	-70.02%
2021	995.97 Billion IDR	54.26%
2020	645.63 Billion IDR	87.73%
2019	343.92 Billion IDR	176.52%
2018	124.37 Billion IDR	27.5%
2017	97.54 Billion IDR	57.35%
2016	61.99 Billion IDR	221.26%
2015	19.29 Billion IDR	0.0%

Year	Net Income	Net Income Growth
2024 Q3	125 Billion IDR	-17.88%
2024 Q2	152.21 Billion IDR	-20.29%
2024 Q1	190.94 Billion IDR	115.74%
2023 Q3	146.49 Billion IDR	56.78%
2023 Q2	93.44 Billion IDR	-14.19%
2023 Q1	108.9 Billion IDR	105.2%
2023 FY	437.34 Billion IDR	46.47%
2023 Q4	88.5 Billion IDR	-39.59%
2022 Q1	111.24 Billion IDR	-51.63%
2022 FY	298.59 Billion IDR	-70.02%
2022 Q4	53.07 Billion IDR	-34.59%
2022 Q3	81.13 Billion IDR	52.69%
2022 Q2	53.13 Billion IDR	-52.23%
2021 Q3	228.49 Billion IDR	-12.59%
2021 Q1	283.25 Billion IDR	33.88%
2021 Q2	261.4 Billion IDR	-7.71%
2021 FY	995.97 Billion IDR	54.26%
2021 Q4	229.98 Billion IDR	0.65%
2020 Q4	211.56 Billion IDR	34.4%
2020 Q2	32.39 Billion IDR	-54.9%
2020 Q3	157.41 Billion IDR	385.88%
2020 Q1	71.84 Billion IDR	58.54%
2020 FY	645.63 Billion IDR	87.73%
2019 Q3	85.41 Billion IDR	25.27%
2019 Q1	56.45 Billion IDR	299.12%
2019 FY	343.92 Billion IDR	176.52%
2019 Q4	45.31 Billion IDR	-46.95%
2019 Q2	68.18 Billion IDR	20.78%
2018 Q1	37.09 Billion IDR	211.36%
2018 FY	124.37 Billion IDR	27.5%
2018 Q4	14.14 Billion IDR	-64.81%
2018 Q3	40.19 Billion IDR	22.01%
2018 Q2	32.94 Billion IDR	-11.2%
2017 Q2	35.3 Billion IDR	0.0%
2017 Q1	35.3 Billion IDR	0.0%
2017 Q3	14.97 Billion IDR	-57.58%
2017 Q4	11.91 Billion IDR	-20.43%
2017 FY	97.54 Billion IDR	57.35%
2016 FY	61.99 Billion IDR	221.26%
2015 FY	19.29 Billion IDR	0.0%

Peer Net Income Comparison of PT Medikaloka Hermina Tbk

Name	Net Income	Net Income Difference
PT Bundamedik Tbk	7.46 Billion IDR	-5761.656%
PT Metro Healthcare Indonesia Tbk	-110.91 Billion IDR	494.29%
PT Mitra Keluarga Karyasehat Tbk	916.13 Billion IDR	52.262%
PT Murni Sadar Tbk	-12.83 Billion IDR	3508.303%
PT Famon Awal Bros Sedaya Tbk	216.97 Billion IDR	-101.566%
PT Royal Prima Tbk	-2.74 Billion IDR	16023.748%
PT Kedoya Adyaraya Tbk	25.18 Billion IDR	-1636.269%
PT Sarana Meditama Metropolitan Tbk	12.25 Billion IDR	-3469.532%
PT Siloam International Hospitals Tbk	1211.28 Billion IDR	63.894%
PT Sejahteraraya Anugrahjaya Tbk	-38.49 Billion IDR	1236.259%